Earnings History Data for Bristol-Myers Squibb Company (BMY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
26-07-2024 PM BMY Bristol-Myers Squibb Company 90,530 2.07 1.64 1.75 Bristol-Myers Squibb Company  Non-GAAP EPS of $2.07 beats by $0.44, revenue of $12.2B beats by $680M
[7/26/2024 7:00 AM]
50.42 5.15 
(11.39%)
48.13 2.86 
(6.32%)
39.35 - 63.89 28,773,161 16,940,000 1,523,441
25-04-2024 PM BMY Bristol-Myers Squibb Company 99,070 1.90 1.53 2.05 Bristol-Myers Squibb Company  Non-GAAP EPS of -$4.40 beats by $0.02, revenue of $11.78B beats by $330M
[4/25/2024 7:01 AM]
44.74 -4.12 
(-8.43%)
47.50 -1.36 
(-2.78%)
44.37 - 70.93 40,661,824 11,420,000 267,928
02-02-2024 PM BMY Bristol-Myers Squibb Company 99,440 1.70 1.52 1.82 Bristol-Myers Squibb beats top-line and bottom-line estimates; initiates FY24 outlook
[2/2/2024 7:01 AM]
48.73 0.06 
(0.12%)
49.25 0.58 
(1.19%)
48.08 - 75.18 20,776,985 15,280,000 1,767,605
26-10-2023 PM BMY Bristol-Myers Squibb Company 117,240 2.00 1.76 1.99 Bristol-Myers Squibb Company Non-GAAP EPS of $2.00 beats by $0.23, revenue of $10.97B in-line
[10/26/2023 7:03 AM]
53.01 -3.60 
(-6.37%)
53.82 -2.79 
(-4.93%)
52.98 - 81.43 20,835,611 11,700,000 1,099,419
27-07-2023 PM BMY Bristol-Myers Squibb Company 135,990 1.75 2.00 1.93 Bristol-Myers Squibb Company Non-GAAP EPS of $1.75 misses by $0.24, revenue of $11.2B misses by $610M
[7/27/2023 7:00 AM]
60.76 -2.65 
(-4.18%)
60.81 -2.60 
(-4.10%)
60.38 - 81.43 18,678,296 8,490,000 968,672
27-04-2023 PM 7:00 AM ET
(Apr 27)
BMY Bristol-Myers Squibb Company 147,740 2.05 1.98 1.96 Bristol-Myers Squibb Company  Non-GAAP EPS of $2.05 beats by $0.05, revenue of $11.3B misses by $290M
[4/27/2023 7:33 AM]
67.58 -0.44 
(-0.64%)
67.94 -0.08 
(-0.12%)
65.28 - 81.43 8,604,214 6,400,000 40,423
02-02-2023 PM 7:00 AM ET
(Feb 2)
BMY Bristol-Myers Squibb Company 153,150 1.82 1.71 1.83 Bristol-Myers Squibb Company  Non-GAAP EPS of $1.82 beats by $0.09, revenue of $11.4B beats by $200M
[2/2/2023 7:00 AM]
72.81 1.58 
(2.22%)
71.75 0.52 
(0.73%)
62.90 - 81.43 9,966,219 8,220,000 53,544
25-10-2022 PM 7:00 AM ET
(Oct 26)
BMY Bristol-Myers Squibb Company 155,850 1.99 1.83 2.00 Bristol Myers Squibb Non-GAAP EPS of $1.99 beats by $0.16, revenue of $11.22B beats by $40M, re-affirms FY22 outlook
[10/26/2022 3:17 AM]
74.41 1.64 
(2.25%)
72.50 -0.27 
(-0.37%)
53.22 - 80.59 8,197,383 8,000,000 60,499
27-07-2022 PM 7:00 AM ET
(Jul 27)
BMY Bristol-Myers Squibb Company 155,320 1.93 1.79 1.93 Bristol Myers Squibb Non-GAAP EPS of $1.93 beats by $0.12, revenue of $11.9B beats by $400M, cuts FY22 outlook
[7/27/2022 7:02 AM]
74.72 1.09 
(1.48%)
72.20 -1.43 
(-1.94%)
53.22 - 80.59 7,464,561 9,070,000 84,450
29-04-2022 PM 7:00 AM ET
(Apr 29)
BMY Bristol-Myers Squibb Company 161,110 1.96 1.92 1.74 Bristol Myers Squibb Non-GAAP EPS of $1.96 beats by $0.07, revenue of $11.6B beats by $260M
[4/29/2022 7:01 AM]
75.29 -1.91 
(-2.47%)
73.50 -3.70 
(-4.79%)
53.22 - 78.17 22,866,356 13,990,000 163,078
04-02-2022 PM 7:00 AM ET
(Feb 4)
BMY Bristol-Myers Squibb Company 143,830 1.83 1.83 1.46 Bristol Myers Squibb Non-GAAP EPS of $1.83 beats by $0.03, revenue of $12B in-line
[2/4/2022 7:00 AM]
65.00 0.93 
(1.45%)
63.10 -0.97 
(-1.51%)
53.22 - 69.75 10,652,060 13,910,000 190,279
27-10-2021 PM 7:00 AM ET
(Oct 27)
BMY Bristol-Myers Squibb Company 127,990 2.00 1.91 1.63 Bristol Myers Squibb EPS beats by $0.08, beats on revenue, boost guidance
[10/27/2021 7:02 AM]
56.49 -1.75 
(-3.00%)
56.49 0.0 
(0.00%)
56.11 - 69.75 18,450,664 9,380,000 91,210
28-07-2021 PM 7:00 AM ET
(Jul 28)
BMY Bristol-Myers Squibb Company 151,140 1.93 1.88 1.63 Bristol Myers Squibb EPS beats by $0.03, beats on revenue
[7/28/2021 7:00 AM]
68.73 1.24 
(1.84%)
68.73 0.0 
(0.00%)
56.75 - 68.99 10,394,788 8,430,000 14,383
29-04-2021 PM 7:00 AM ET
(Apr 29)
BMY Bristol-Myers Squibb Company 147,190 1.74 1.83 1.72 Bristol Myers Squibb EPS misses by $0.07, misses on revenue
[4/29/2021 7:04 AM]
62.89 -3.14 
(-4.76%)
62.89 0.0 
(0.00%)
54.07 - 67.16 21,099,286 11,000,000 15,823
04-02-2021 PM 7:00 AM ET
(Feb 4)
BMY Bristol-Myers Squibb Company 142,230 1.46 1.37 1.22 Bristol Myers Squibb EPS beats by $0.04, beats on revenue
[2/4/2021 7:02 AM]
61.56 -0.29 
(-0.76%)
61.74 -0.29 
(-0.47%)
45.76 - 67.80 13,121,654 13,346,295 70,406
05-11-2020 PM 7:00 AM ET
(Nov 5)
BMY Bristol-Myers Squibb Company 138,030 1.63 1.49 1.17 Bristol Myers Squibb EPS beats by $0.14, beats on revenue
[11/5/2020 7:01 AM]
63.75 -1.68 
(-2.57%)
63.75 0.0 
(0.00%)
45.76 - 68.34 13,304,474 11,304,800 534,460
06-08-2020 PM 7:00 AM ET
(Aug 6)
BMY Bristol-Myers Squibb Company 133,720 1.63 1.43 1.18 Bristol Myers Squibb EPS beats by $0.16, beats on revenue
[8/6/2020 7:01 AM]
61.50 1.82 
(3.04%)
62.20 2.51 
(4.21%)
45.00 - 68.34 10,931,843 9,626,580 457,891